Drug Type Synthetic peptide |
Synonyms |
Target |
Action agonists |
Mechanism ACTH receptor agonists(Melanocortin receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Membranous Glomerulonephritis | Phase 3 | United States | 13 Mar 2023 | |
Idiopathic Membranous Glomerulonephritis | Phase 3 | India | 13 Mar 2023 | |
Idiopathic Membranous Glomerulonephritis | Phase 3 | Canada | 13 Mar 2023 |